ExCulture

ExCulture is a Leiden-based biotech startup developing an animal-free heparin alternative using scalable mixed-culture fermentation to address global heparin shortages. Founded in 2022 and backed by investors including Capricorn Partners and DSM-Firmenich, it aims to replace animal-derived heparin in the US and Europe.